57 results
6-K
EX-99.1
8uzh7rc o3qwyv1o6bl
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
pa40zruumqfo9
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
nyl7c8zj
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-99.1
h047 f5xgo87
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.2
rujo8o6
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-10.1
9yj46z
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
hj6k36euf1wp4ekjstd
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-99.4
2roh ufcfoegbpmd
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
1pgu1c
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-1.1
42pqak3u1yp95ds6vn
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
n2pqywx
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-1.1
93xe1h aupx
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm